Skip to content
Recall Observatory FDA recall evidence

Drug product

Effexor XR (venlafaxine HCl) Extended-Release Capsules, 150 mg, packaged in a) 30-count Unit of Use bottles (NDC 0008-0836-21) UPC 3 0008-0836-21 7; b) 90-count Unit of Use bottles (NDC 0008-0836-22) UPC 3 0008-0836-22 4; Rx only, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA 19101.

D-1328-2014

March 06, 2014

Class I

Product summary

Firm
Pfizer Us Pharmaceutical Group
Event
Event 67636
Status
Terminated
Classification
Class I
Quantity
49,847 bottles
Official record key
drug-enforcement:D-1328-2014

Official wording

Reason: Presence of Foreign Tablets/Capsules: A Pharmacist reported that a bottle of Effexor XR 150 mg capsules contained a single peach colored capsule printed TKN250 which was identified as a Tikosyn (dofetilide) capsule.

Code information: Lot #: a) V130142, Exp 10/15; b) V130140, Exp 10/15

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Tablets